Den anden omfattede 552 patienter, der var HBeAg - negative (dvs. smittet med et virus, der har muteret (ændret sig) og er årsag til en form for kronisk hepatitis B, som er vanskeligere at behandle).
In all cases, the main measure of effectiveness was the disappearance of the markers of hepatitis virus infection from the blood after treatment and at ‘ follow-up’ six months later.